n elevated IgE antibody response is a hallmark of infection with parasitic helminths, including Schistosoma mansoni, which infect an estimated 250 million people worldwide (1) (2) (3) . It is a widely accepted hypothesis that this IgE response evolved as a host defense against metazoan parasites (4, 5) . Certainly, numerous studies support the hypothesis that IgE is important in acquired resistance to secondary schistosome infection: B cell depletion prevents development of immunity (6) , effective immunity can be adoptively transferred by IgE antibodies (7, 8) , and in vitro IgE can directly mediate resistance through eosinophil, macrophage, and platelet-mediated cytotoxicity (4, 9, 10) . In addition, recent epidemiological reports suggest a correlation between high schistosome-specific IgE antibody levels and resistance to reinfection (11) (12) (13) . On the other hand, studies of vaccine-induced immunity suggest that IFN-% rather than IgE, is the important effector molecule for acquired immunity (14, 15) . Indeed, treatment with an anti-IFN-v antibody has been shown to reduce immunity to schistosomiasis (16) .  has also been implicated in schistosome egg-induced granuloma formation (17) .
In this study, we evaluated the contributions of IgE and IFN-y in the host defense against a primary infection with S. mansoni. The relative roles of IgE and IFN-3, were examined in a murine model of schistosomiasis in which IgE was eliminated using a monoclonal anti-IgE antibody, and IFN-3, was eliminated via gene knockout (GKO) 1 (18) . We report that anti-IgE mAb treatment of both wild type and GKO mice completely blocked production of IgE, yet reduced the number of adult worms and dramatically reduced egg production leading to amelioration of hepatosplenomegaly. These findings suggest that in primary infections, the IgE response stimulated by S. mansoni infection is an immunopathological consequence of the host-parasite interaction rather than a protective immune response.
Affairs Medical Center by using golden Syrian hamsters as the final host, and Biomphalaria glabrata snails as the intermediate host. Cercariae of S. mansoni were collected by placing infected snails in a darkroom for 3-4 d. Shedding of cercariae into spring water (with 100/~g/ml gentamycin) was induced by placing snails under an incandescent light for 2 h.
Infection of Mice with S. mansoni Cercariae. BALB/c and (129 /SvXC57BL/6)F2 (wild-type) mice were purchased from Charles River Laboratories (Portage, MI). IFN-y (GKO) mice were obtained from a breeding colony at Genentech. All the mice were housed under microisolator caps in a quarantine room. Once acclimated to our facility, the 5-7-wk-old mice were treated intravenously with either 100 #g anti-lgE mAb (K35-92, rat IgG1; Pharmingen, San Diego, CA) or an isotype-matched control antibody (rat IgGl,r; PharMingen). The next day, all the mice were injected subcutaneously with 90 _-4-5 cercariae of S. mansoni. At weekly intervals, mice were bled and then retreated intravenously with 20 #g anti-lgE mAb or isotype-matched control antibody at weeks 1, 2, 3, 4, and 5 and with 100 #g at weeks 6 and 7 (total of 400 #g), or with 20 #g anti-IgE mAb weekly (total of 240 #g). GKO mice (5-9 per group) were treated with a total of 400 #g of the anti-lgE mAb or the isotype control. Total serum IgE was determined by ELISA. There was no effect of the rat anti-IgE Ab on the ability to detect IgE using this assay format. frosted glass slides and 106 cells/ml were cultured in DMEM containing 10% FBS, 5 x 10-s M 2-ME, 100 U/ml penicillin, and 100 mg/ml streptomycin (GIBCO BILL) at 37~ 5% CO2. 5 #g/ml Con A was added at initiation of the culture, and supernatants for ELISA were harvested after 72 h. ELISA. Microtiter plates (Immuno MaxiSorp; Nunc, Koskilde, Denmark) were coated overnight at 4~ with either 2 #g/ml polyclonal rabbit anti-mouse IgE, 1 #g/ml rat anti-mouse I1;4 mAb (BVD4-1D11, IgG2b), or I #g/ml hamster anti-recombinant mlFN-% depending on the assay format, in 0.05 M sodium carbonate/bicarbonate, pH 9.6. Plates were washed with PBS/0.1% Tween 20 and unbound protein sites were blocked for I h at room temperature with 100 #1 of 50 mM TBS/0.5% BSA/2 mM EDTA/0.05% Tween 20 (ELISA buffer). After washing three times, twofold dilutions of serum from treated mice or supernatants from cultured splenocytes were added for 2 h and then washed. To detect total serum IgE, biotinylated lgE receptor I-IgG immunoadhesin (1:1,000 in ELISA buffer) was added and plates were incubated for 90 min at room temperature. The plates were washed and incubated for 1 h with horseradish peroxidase conjugated to streptavidin (1:4,000 in ELISA buffer) followed by washing and the addition of the developing substrate o-phenylenediamine dihydrochloride (OPD, Sigma Chemical Co.).
II.-4 concentrations were determined using biotin-conjugated anti-mouse 11.-4 (BVD6-24G2, rat IgG1; 1 #g/ml in ELISA buffer). After washing, the plates were incubated for 1 h with horseradish peroxidase conjugated to streptavidin (1:4,000 in ELISA buffer) followed by OPD.
IFN-3~ in supernatants from Con A-stimulated splenocytes was detected with rabbit anti-recombinant mlFN-y followed by a 90-min incubation with horseradish peroxidase-conjugated donkey anti-rabbit lg (1:5,000 in ELISA buffer) before the developing substrate OPD was added.
Results
We began with an examination of the role of IgE in primary schistosome infection. In the first series of experiments, normal BALB/c mice were infected with S. mansoni cercariae and treated weekly with a total of 400/~g of anti-IgE mAb (high dose). This treatment reduced serum IgE to undetectable levels (<3 ng/ml) during the 8-wk course of the infection (Fig. 1) . The assay used for quantitation of IgE detects both free IgE and IgE complexed to the antibody and, as such, measures the total serum IgE concentration. A second group of mice treated with a lower dose of anti-IgE mAb weekly (240 #g/total) had measurable IgE responses (<50 #g/ml) during the last 2 wk of the infection. The IgE levels in the antibody treated mice were markedly reduced compared with infected mice treated with the isotype control an- Week of Infection Figure 1 . Effect of anti-IgE mAb or control antibody treatment on total serum IgE levels in BALB/c mice. All the mice were treated with 100 #g of anti-IgE mAb or the isotype-matched control IgG antibody I d before exposure to parasites. At weekly intervals, mice were bled and then retreated intravenously with a total of 400 or 240 #g of anti-IgE mAb or IgG. Total serum IgE was determined by ELISA using polyclonal rabbit anti-mouse IgE.
tibody which exhibited typically high serum IgE levels (240 /zg/ml) by the eighth week of infection.
In agreement with previous reports, a significant but incomplete reduction in serum IgE levels had little effect on either parasite burden or the number of eggs produced per worm (Table 1 ). In contrast, infected mice, which had undetectable IgE levels as a result of treatment with the higher dose of anti-IgE mAb, had a significant reduction in the number of adult worms and the number of eggs produced, as compared with the control group.
The reduction in egg production resulting from antibody treatment had a measurable effect on the cellular response to infection. Granuloma formation around schistosome eggs trapped in the portal venules of the liver is the key pathological event in schistosomiasis (21, 22) . Histopathological examination of the infected animals revealed that organ size correlated with the tissue inflammatory response (Fig. 2 A) . In the high dose mAb-treated mice, hepatosplenomegaly was diminished by ~o50% when compared with control IgG treated mice. This was due to the decrease in egg production which in turn resulted in marked reductions in the number of granulomas in the livers of the high dose anti-IgE mab treated mice (Fig. 2 B) .
The cellular composition of the granulomas was not appreciably altered. Well developed granulomas with numerous macrophages and eosinophils were observed in all groups of mice. However, the high dose treatment group did show decreased granuloma-associated fibrosis (Fig. 2, C and D) . Additional immunohistochemical staining of the inflammatory infiltrate for reticulin fibers (data not shown) revealed little fibrosis around the eggs in the anti-IgE treated mice, whereas a distinct fibrotic reaction was evident around the eggs in the IgG controls.
In addition to eliciting a potent inflammatory response, schistosome eggs are a powerful stimulus for donal expansion and activation of the Th2 subclass of CD4 + T cells (23, 24) which release specific cytokines, including IL-4 (25) . In these experiments, serum IL-4 rose to detectable levels during the seventh and eighth weeks of infection in control antibody treated mice (Fig. 3) . This rise coincided with egg production (26). However, there was no similar spike of IL-4 in the sera of infected mice treated with anti-IgE mAb (Fig. 4) .
The decrease in IL-4 levels after anti-IgE treatment of schistosome-infected mice was reflected in differential surface marker expression of splenic B cells in the treated mice examined at 8 wk after infection with cercariae. Examination of FceRII (CD23), the low affinity receptor for IgE, on splenic B cells revealed that the receptor level was elevated in response to schistosome infection in the control mice. This increased expression was not seen in mice treated with the anti-IgE mAb (Fig. 4) . Since IL-4 is known to increase cell surface expression of CD23 (27) , the lack of enhanced CD23 expression is consistent with the absence of detectable IL-4 levels in the anti-IgE treated mice.
To investigate the relative contribution of Thl-derived cytokines in this system, sera were assayed for IFN-y which has been shown to confer vaccine-induced protective immunity to S. mansoni (28) . Although the ELISA used was sensitive to 15 pg/ml, no circulating IFN-'y was detected in any of the serum samples collected during the 8-wk course of primary schistosome infection (data not shown). However, IFN-3, levels were measurable in the supernatants of Con A-stimulated spleen cells taken from either uninfected mice or from infected mice treated with anti-IgE or control antibody. In agreement with published findings (29) , IFN-qr levels in the cultures were greatly suppressed 8 wk after infection (560 pg/ml uninfected mice vs. 18 pg/ml infected mice). It is interesting to note that treatment with the anti-IgE antibody partially reversed this suppression elevating IFN-3' to 67 pg/ml in the supernatants of splenocytes from infected mice.
To investigate the role of IFN-3' in the immune response to primary S. mansoni infection in the anti-IgE treated mice, GKO mice were infected with the parasite and treated with the anti-IgE or control antibody (Fig. 5) . It is surprising that GKO and wild-type mice treated with the control antibody were found to have equivalent responses to the parasites (Fig.  6) . Almost identical numbers of worms and eggs were recovered from each group. Furthermore, there were no differences in the number or appearance of granulomas in the two groups. However, similar to the results seen in the BALB/c mice, treatment of the GKO mice with the anti-IgE antibody did result in a decrease in worm burden and egg production. Thus, the effect of anti-IgE treatment would appear to be independent of IFN-3,.
The lack of IFN-3, production in the GKO mice was confirmed by the absence of IFN-3' after Con A stimulation of splenocytes (Fig. 7 A) . Given the well-established suppressive effects of IFN-3, on IgE synthesis, it is noteworthy that serum IgE levels in the GKO mice were not elevated compared with wild-type mice. This may reflect lower IL-4 levels in these mice since in this experiment, splenocytes from the GKO Figure 2 . Cellular reaction to schistosome eggs trapped in the liver of schistosome-infected BALB/c mice. Liven from control antibody treated mice contained multiple large coalescing loci of granulomas predominately composed of macrophages and eosinophils (A). Livers of anti-lgE mAb treated animals had fewer eggs and therefore fewer granulomas (B). The histologic characteristics, notably the presence of macrophages and numerous eosinophils, were similar in both groups. However, the granulomas of the anti-lgE treated group (D) did appear to have less fibrosis than those from control mice (C). mice produced decreased levels of IL-4 in response to Con A stimulation (Fig. 7 B) .
Discussion
It has been difficult to determine the precise role of IgE in models of parasite infection since most of the studies have employed systems in which IgE is deficient as a result of genetic mutation(s) or via elimination of the pluripotent lymphokine IL-4 which acts as a switch factor for IgE and IgG1 and is required for IgE synthesis (30) . Treatment of mice with anti-IL-4 antibodies reduced serum IgE along with IL-4, but failed to alter immunity against S. mansoni (15). Since both IL-4 and IgE levels were affected in this study, it is difficult to separate the effects of removal of IgE alone from the pluripotent effects of IL-4 removal. Likewise, attempts to suppress only IgE levels using a polyclonal anti-IgE antiserum showed no detrimental effect on curing a primary infection orS. mansoni in rats (31) . However, since that study measured only worm-specific IgE responses, it is unclear to what degree the nonspecific IgE response or the IgE response to the other forms of the parasite was suppressed by the dose of anti-IgE antibody used. It has been shown that schistosome-specific IgE constitutes <10% of the total IgE made in response to the infection (32) . The suggestion has been made that the presence of this disproportionately high level of total nonparasite IgE may be protective for the parasite since these IgE molecules would saturate the available FceRs and prevent parasite antigen-specific mediator release (33) . Here we measured the total IgE response to assure that the nonspecific IgE levels were completely suppressed throughout the entire course of the infection. Measurement of antigen-specific IgE titers confirmed this result (data not shown). Clearly, suppression of the total IgE response to undetectable levels, rather than a partial reduction in IgE levels, was beneficial for the host as measured by decreases in worm burden and egg production. This reduction in egg production does not appear to wt-lgG GKO-IgG GKO-anti-lgE wt-lgG GKO-IgG GKO-anti-lgE Figure 7 . Con A-stimulated IFN-3r and IL-4 production by splenocytes from schistosome-infected GKO or wild-type mice treated with either antiIgE mAb or isotype control.
be due to a shift in kinetics, since in other reinfection experiments, identical results were seen as late as 15 wk after infection (our unpublished results).
The reduction in egg production in the anti-IgE treated mice is striking. Since it has been shown that TNF-ot is required for egg laying by schistosomes (34) the reduction in IgE levels after antibody treatment may have resulted in a reduction in the IgE-dependent release of TNF-ot by peritoneal mast cells (35, 36) . The lack of IgE to trigger mast cell degranulation would lead to lower TNF-o~ levels and could account for the decreased egg production in the anti-IgE treated mice. This condusion is supported by the results seen in the low dose anti-IgE treated mice. In this experiment, when IgE was detectable during the last 2 wk of the infection, egg production and the resultant hepatosplenomegaly were equivalent to the control antibody treated animals.
The decrease in egg production would be expected to have an impact on the cellular response to this parasite since schistosome eggs are known to be potent inducers of Th2 cells. Thus, the decreased egg numbers may have resulted in decreased Th2 stimulation thereby decreasing IL-4 production since Th2 cells are a primary source of this cytokine. This could account for the decreased IL-4 levels observed in the anti-IgE treated mice. Alternatively, as suggested for TNF-c~, decreased IgE levels after antibody treatment could lead to decreased mast cell degranulation and release of IL-4 from the granules since it has been shown that mast cells are an important source of IL-4 which is released after receptor cross-linking (37) . Indeed, FceR-positive cells are a major source of IL-4 in spleens of mice infected with S. mansoni (38) . These findings suggest that in addition to IL-4 directing IgE synthesis, IgE feeds back to amplify IL-4 release, thus modulating its own production.
Decreased IL-4 levels could also account for the observed decrease in CD23 expression since IL-4 is known to be involved in upregulation of CD23 expression. CD23 can act quite efficiently in the capture and preferential presentation of antigens to Th2 cells (39) leading to induction of IgE responses. Thus, a reduction in CD23 expression would lead to a further decrease in Th2 stimulation.
Previous reports have established an association with Thl stimulation and protection against adult worms versus Th2 stimulation and egg-induced immunopathology (40) . It has also been suggested that the Th2 response to schistosome eggs results in downregulation of the Thl response (37) . The improved response to the parasite after elimination of IgE via anti-IgE treatment may result from shifting the balance from a Th2 towards a Thl response, resulting in the production of cytokines that are reported to be more effective in controlling the parasite infection (17) . The increase in IFN-y levels observed after anti-IgE treatment suggested this shift toward a Thl response was occurring.
We tested the role of IFN-3, directly by treating schistosomeinfected mice, defective in the IFN-3' gene, with the antiIgE antibody. Since there was little difference in the ability of wild-type or GKO mice to respond to infection, the data suggest that IFN-y does not play a central role in the development of immunity to primary schistosome infection. Nevertheless, elimination of IFN-3' with an anti-IFN-3, antibody has been shown to reduce vaccine-induced immunity to schistosomiasis (15) .
Treatment of the GKO mice with the anti-IgE antibody did result in a decrease in worm burden and egg production. Thus it would appear that the protective effect of the antiIgE treatment is independent of IFN-3, production. IFN-3, is well accepted as a downregulator of IgE synthesis (41) . If IgE plays a negative role in immunity to schistosomiasis, then one may speculate that the reduction in immunity as a consequence of decreased IFN-y levels resulted from an increase in IgE production. Indeed, in other experiments in mice unable to produce IFN-y because of disruptions of their IFN genes, we observed enhanced IgE production in response to bacillus Calmette Gu&in infection (our unpublished observations).
